GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Cyclically Adjusted PS Ratio

Theragen Etex Co (XKRX:066700) Cyclically Adjusted PS Ratio : 0.53 (As of Jun. 04, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Theragen Etex Co's current share price is ₩3010.00. Theragen Etex Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩5,648.42. Theragen Etex Co's Cyclically Adjusted PS Ratio for today is 0.53.

The historical rank and industry rank for Theragen Etex Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:066700' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.52   Med: 1.47   Max: 4.95
Current: 0.53

During the past years, Theragen Etex Co's highest Cyclically Adjusted PS Ratio was 4.95. The lowest was 0.52. And the median was 1.47.

XKRX:066700's Cyclically Adjusted PS Ratio is ranked better than
84.69% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs XKRX:066700: 0.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Theragen Etex Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩2,039.672. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩5,648.42 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Theragen Etex Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Theragen Etex Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Cyclically Adjusted PS Ratio Chart

Theragen Etex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.60 1.55 0.96 0.89 0.57

Theragen Etex Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.70 0.64 0.57 0.52

Competitive Comparison of Theragen Etex Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Theragen Etex Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theragen Etex Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Theragen Etex Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Theragen Etex Co's Cyclically Adjusted PS Ratio falls into.


;
;

Theragen Etex Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Theragen Etex Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3010.00/5648.42
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theragen Etex Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Theragen Etex Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2039.672/122.5900*122.5900
=2,039.672

Current CPI (Mar. 2025) = 122.5900.

Theragen Etex Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 926.107 100.051 1,134.739
201509 913.068 100.111 1,118.091
201512 1,036.045 100.220 1,267.294
201603 840.515 100.561 1,024.640
201606 820.089 100.791 997.460
201609 845.079 101.461 1,021.063
201612 1,062.071 101.561 1,281.977
201703 815.623 102.851 972.160
201706 1,056.857 102.611 1,262.630
201709 926.796 103.491 1,097.839
201712 1,089.844 102.991 1,297.242
201803 876.433 104.101 1,032.095
201806 849.152 104.130 999.685
201809 992.127 105.651 1,151.200
201812 1,185.770 104.351 1,393.029
201903 1,001.739 104.491 1,175.252
201906 1,214.137 104.881 1,419.144
201909 1,103.834 105.200 1,286.299
201912 1,123.395 105.121 1,310.077
202003 967.200 105.354 1,125.433
202006 1,090.710 105.112 1,272.075
202009 1,231.843 106.198 1,421.987
202012 1,172.443 105.765 1,358.949
202103 1,179.936 107.357 1,347.356
202106 1,253.467 107.579 1,428.374
202109 1,334.919 108.759 1,504.679
202112 1,449.345 109.676 1,619.995
202203 1,492.679 111.848 1,636.037
202206 1,420.194 114.072 1,526.239
202209 1,490.037 114.715 1,592.321
202212 1,570.542 115.179 1,671.593
202303 1,570.949 116.507 1,652.965
202306 1,585.921 117.182 1,659.111
202309 1,683.914 118.964 1,735.245
202312 1,888.012 118.837 1,947.636
202403 1,832.844 120.123 1,870.483
202406 1,981.877 120.007 2,024.529
202409 2,228.407 120.861 2,260.282
202412 1,528.979 121.135 1,547.342
202503 2,039.672 122.590 2,039.672

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Theragen Etex Co  (XKRX:066700) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Theragen Etex Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Theragen Etex Co Business Description

Traded in Other Exchanges
N/A
Address
58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines